Latest Whitepapers

Download this whitepaper to discover how high-throughput flow cytometry can provide quantitative data on binding, antibody internalization and antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis and T-cell activation.

Download this whitepaper to discover how CRISPR can overcome antibiotic-resistant and pathogenic bacteria.

Respiratory syncytial virus (RSV) has a high mortality rate and is the leading cause of lower respiratory tract infections in children and infants worldwide.

The COVID-19 pandemic has continued to spread worldwide, with an increasing number of global infections and the continual emergence of new variants. Are the existing vaccines still effective against new variants?

Quality Assurance in In Vitro Transcribed RNA Vaccine Development Using Agilent Automated Electrophoresis Instruments

Download this whitepaper to discover assay development tools that can help you to image various dyes with different excitation and emission wavelengths, achieve a high degree of photostability as well as detect the presence of proteins including SARS-CoV-2's spike protein.

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?

Download this whitepaper to discover how a contract development manufacturing organization was able to establish an AAV production platform and much more.

The efficiency of candidate antibody discovery pipelines is directly connected to the quality of the DNA library being screened. To reduce discovery timelines, researchers need access to tools allowing them to take more shots on goal, as well as line up these shots effectively.

Immunotherapy has the potential to treat a wide variety of conditions, from autoimmune disease to cancer. However, the discovery of potential antibody therapeutics against key receptor proteins remains a major challenge for the traditional immunisation approaches currently available on the market.